Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saratchandra Singh Khumukcham

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Biochimica Et Biophysica Acta. Reviews on Cancer|June 6, 2021
Two decades of a protooncogene HPIP/PBXIP1: Uncovering the tale from germ cell to cancerSaratchandra Singh Khumukcham, Bramanandam Manavathi
RSC Advances|May 6, 2022
Effective <i>in vitro</i> delivery of paclitaxel by nanocargo of mesoporous polycaprolactone against triple negative breast cancer cells by minimalizing drug doseHimadri Medhi, Saratchandra Singh Khumukcham, Bramanandam Manavathi, et al.
Frontiers in Cell and Developmental Biology|May 14, 2026
Decoding Rho GTPase signalling networks in directed cell migrationYasaswi Gayatri Mishra, A Indumathi, Saratchandra Singh Khumukcham, et al.
Cancer Letters|July 24, 2021
HPIP protooncogene differentially regulates metabolic adaptation and cell fate in breast cancer cells under glucose stress via AMPK and RNF2 dependent pathwaysVasudevarao Penugurti, Saratchandra Singh Khumukcham, Chiranjeevi Padala, et al.
The FEBS Journal|October 20, 2021
Hematopoietic PBX-interacting protein is a novel regulator of mammary epithelial cell differentiationAnju Dwivedi, Chiranjeevi Padala, Anita Kumari, et al.
The Biochemical Journal|February 28, 2016
A transcriptional repressive role for epithelial-specific ETS factor ELF3 on oestrogen receptor alpha in breast cancer cellsVijaya Narasihma Reddy Gajulapalli, Venkata Subramanyam Kumar Samanthapudi, Madhusudana Pulaganti, et al.
Cellular Signalling|January 30, 2025
Potential role of Hematopoietic PBX-Interacting Protein (HPIP) in trophoblast fusion and invasion: Implications in pre-eclampsia pathogenesisVasudevarao Penugurti, Oindrilla Dey, Sruchytha Kalali, et al.
The Journal of Biological Chemistry|May 19, 2019
Hematopoietic PBX-interacting protein is a substrate and an inhibitor of the APC/C-Cdc20 complex and regulates mitosis by stabilizing cyclin B1Saratchandra Singh Khumukcham, Venkata Subramanyam Kumar Samanthapudi, Vasudevarao Penugurti, et al.
Cancer Letters|November 12, 2021
A reciprocal feedback loop between HIF-1α and HPIP controls phenotypic plasticity in breast cancer cellsSaratchandra Singh Khumukcham, Vasudevarao Penugurti, Anita Soni, et al.
The Journal of Biological Chemistry|October 5, 2023
HPIP and RUFY3 are noncanonical guanine nucleotide exchange factors of Rab5 to regulate endocytosis-coupled focal adhesion turnoverSaratchandra Singh Khumukcham, Vasudevarao Penugurti, Suresh Bugide, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Biochimica Et Biophysica Acta. Reviews on Cancer|June 6, 2021
Two decades of a protooncogene HPIP/PBXIP1: Uncovering the tale from germ cell to cancerSaratchandra Singh Khumukcham, Bramanandam Manavathi
RSC Advances|May 6, 2022
Effective <i>in vitro</i> delivery of paclitaxel by nanocargo of mesoporous polycaprolactone against triple negative breast cancer cells by minimalizing drug doseHimadri Medhi, Saratchandra Singh Khumukcham, Bramanandam Manavathi, et al.
Frontiers in Cell and Developmental Biology|May 14, 2026
Decoding Rho GTPase signalling networks in directed cell migrationYasaswi Gayatri Mishra, A Indumathi, Saratchandra Singh Khumukcham, et al.
Cancer Letters|July 24, 2021
HPIP protooncogene differentially regulates metabolic adaptation and cell fate in breast cancer cells under glucose stress via AMPK and RNF2 dependent pathwaysVasudevarao Penugurti, Saratchandra Singh Khumukcham, Chiranjeevi Padala, et al.
The FEBS Journal|October 20, 2021
Hematopoietic PBX-interacting protein is a novel regulator of mammary epithelial cell differentiationAnju Dwivedi, Chiranjeevi Padala, Anita Kumari, et al.
The Biochemical Journal|February 28, 2016
A transcriptional repressive role for epithelial-specific ETS factor ELF3 on oestrogen receptor alpha in breast cancer cellsVijaya Narasihma Reddy Gajulapalli, Venkata Subramanyam Kumar Samanthapudi, Madhusudana Pulaganti, et al.
Cellular Signalling|January 30, 2025
Potential role of Hematopoietic PBX-Interacting Protein (HPIP) in trophoblast fusion and invasion: Implications in pre-eclampsia pathogenesisVasudevarao Penugurti, Oindrilla Dey, Sruchytha Kalali, et al.
The Journal of Biological Chemistry|May 19, 2019
Hematopoietic PBX-interacting protein is a substrate and an inhibitor of the APC/C-Cdc20 complex and regulates mitosis by stabilizing cyclin B1Saratchandra Singh Khumukcham, Venkata Subramanyam Kumar Samanthapudi, Vasudevarao Penugurti, et al.
Cancer Letters|November 12, 2021
A reciprocal feedback loop between HIF-1α and HPIP controls phenotypic plasticity in breast cancer cellsSaratchandra Singh Khumukcham, Vasudevarao Penugurti, Anita Soni, et al.
The Journal of Biological Chemistry|October 5, 2023
HPIP and RUFY3 are noncanonical guanine nucleotide exchange factors of Rab5 to regulate endocytosis-coupled focal adhesion turnoverSaratchandra Singh Khumukcham, Vasudevarao Penugurti, Suresh Bugide, et al.
Pageof 2